Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
Older
Jul 05, 2018
Initial Director's Interest Notice
Jul 05, 2018
Initial Director's Interest Notice
Jul 04, 2018
Neuren announces new appointments to the board of directors
Jun 18, 2018
Results of Meeting
Jun 18, 2018
Chairman's Address at 2018 Annual Shareholders' Meeting
May 30, 2018
Change of Director's Interest Notice
May 30, 2018
Final share buy-back notice - Appendix 3F
May 30, 2018
Announcement of buy-back - Appendix 3C
May 23, 2018
Notice under section 708A(5)(e) of the Corporations Act
May 23, 2018
Appendix 3B
Previous
1
2
3
4
Next
